Marshall Wace, LLP Accelerate Diagnostics, Inc Transaction History

Marshall Wace, LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.54 - $1.41 $30,523 - $79,700	-56,525 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.4 - $5.15 $44,938 - $165,309	-32,099 Reduced 36.22%	56,525 $81,000
Q4 2021 Feb 14, 2022	BUY	$4.27 - $6.97 $299,638 - $489,105	70,173 Added 380.32%	88,624 $464,000
Q3 2021 Nov 15, 2021	BUY	$5.31 - $8.25 $97,974 - $152,220	18,451 New	18,451 $108,000
Q2 2021 Aug 13, 2021	SELL	$6.81 - $9.23 $184,734 - $250,382	-27,127 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.99 - $15.0 $113,745 - $213,540	-14,236 Reduced 34.42%	27,127 $225,000
Q4 2020 Feb 16, 2021	BUY	$7.04 - $11.7 $291,195 - $483,947	41,363 New	41,363 $314,000
Q3 2020 Nov 16, 2020	SELL	$9.98 - $18.04 $1.12 Million - $2.02 Million	-111,739 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$7.49 - $15.16 $571,030 - $1.16 Million	76,239 Added 214.76%	111,739 $1.69 Million
Q1 2020 May 15, 2020	BUY	$4.62 - $18.74 $164,010 - $665,270	35,500 New	35,500 $296,000
Q2 2019 Aug 14, 2019	SELL	$17.79 - $22.88 $269,411 - $346,494	-15,144 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$11.76 - $22.15 $178,093 - $335,439	15,144 New	15,144 $318,000
Q2 2018 Aug 14, 2018	SELL	$19.02 - $24.95 $176,886 - $232,035	-9,300 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$22.55 - $29.9 $209,715 - $278,070	9,300 New	9,300 $213,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.